Member Info for Soupdragon78

You’re about 2 years late to that party Antha

Preferably within this lifetime

Perhaps it’s time for Oxilio to reverse ferret their way in

Not great, looking at a reformulation.

Hanging on to nxp004 still outperforming Olaparib.

Good luck dusty, must be a pain to have to post the same thing across multiple shares over the past four years.
My heart bleeds.

The last Allenby report released alongside the half yearly in December had NXP002 phase 1 ready by H2 2023

ok, so you're upset they're not releasing news that might be negative?

ok, so why do you think they haven't released news of durability data coming back? Do you honestly believe they aren't doing anything or haven't received it?

B009, when did they say they would issue an RNS when they got durability data?

B009,
Its clear DG is in lieu of a BDD as the company hasn't mentioned it since the circular note at the end of January.

Do you really want the company to say they aren't bothering with a CEO? They've stopped looking? What do you think would happen to the sp if they announced that?

Data received from the CRO is not price sensitive as it doesn't affect revenue so doesn't have to be made public.

1-Dan Gooding was brought in as business development consultant in lieu of director level appointment.
2-CEO was progressing, but doesn't mean they have to appoint someone, there may be circumstances that mean one is not required.
3-What makes you think positive data has not been received?

Mars, the tecfidera case was more about a legal dispute, rather than Biogen buying it out of the blue.

Forward Pharma were suing them for infringement of the patent and Tecfidera was already on sale.

Still my favourite

Mulderoutthere
Posted in: NFX
Posts: 13
Price: 0.90
No Opinion
RE: Lynparza in the press.
22 Mar 2022 13:04

Is chat room - make no comment on value - just see you say Lynparza and think not best for repurpose approach - why you talk up bad idea when company not say drug is ?

Remind us again Mulder whay you also posted under the name Foremagnus? Or maybe why you decided to stop posting under that name.
We all preferred it when you struggled to put a sentence together, I guess that guy got a job elsewhere.

oh and should add that IFC advisory are currently linking NFX to a plot line in Neighbours.

Glad they're earning their keep.

Wacca, a few points considering....

JH not selling any of her 37m shares
DG not selling any of his 37m shares
DG & JH both holding 37m options
The current board taking up 3m options in Feb
Chairman buying (albeit modest amount)

Appointing DG as consultant to push commercial aspect of 002.

Never seen anything confirming discussions with AZ before Mars, the company has been clear they are waiting for patent grant first.

How much have you lost blood?

Chab, CPI's sells have all been around the 1.5p region or above. (Mid Feb 22, mid Nov 21)

Ironically you'll pay more to buy right now than the first two buys this morning.